Table: Kringle Pharma -2024/25 parent results

Kringle Pharma

12/11/2025 06:40

Nov 12 (Reuters)- 
          Kringle Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended        Year to         NEXT   
               Sep 30, 2025     Sep 30, 2024     Sep 30, 2026      YEAR     
                  LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS          FORECAST     H1 FORECAST 
  Sales           72 mln           80 mln           72 mln                  
                (-9.8 pct)      (+15.6 pct)       (-0.3 pct)                
  Operating    loss 909 mln     loss 817 mln      loss 1.17                 
  Recurring    loss 914 mln     loss 754 mln      loss 1.17                 
  Net          loss 916 mln     loss 756 mln      loss 1.17                 
  EPS        loss 133.92 yen  loss 118.21 yen  loss 167.21 yen              
  Ann Div          NIL              NIL              NIL                    
  -Q2 Div          NIL              NIL              NIL                    
  -Q4 Div          NIL              NIL              NIL                    
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T